Although low plasma apoE levels increases the risk of not only AD but all types of dementia [18], a peripheral phenotype based on altered plasma apoE levels with relevance to the brain under physiological or neurodegenerative conditions is controversial due to the inability of peripheral apoE to enter the central nervous system (CNS) [19]. The gene discussed is APOE; the disease is Alzheimer disease.